Prophylactic and therapeutic treatment with a high affinity, potent, neutralising anti-IL-13 mAb significantly inhibited HDM-induced airway eosinophilia, goblet cell upregulation and peribronchial collagen deposition. This evidence concerns the gene IL13 and Increased total eosinophil count.